Retatrutide (TFA)
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-P3506A-1MG | 1 mg | 275,00 | Add | |
| HY-P3506A-5MG | 5 mg | 468,00 | Add | |
| HY-P3506A-10MG | 10 mg | 648,00 | Add | |
| HY-P3506A-25MG | 25 mg | 1'024,00 | Add | |
| HY-P3506A-50MG | 50 mg | 1'527,00 | Add | |
| HY-P3506A-100MG | 100 mg | 2'307,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
LY3437943 (TFA)
Retatrutide (LY3437943) TFA is a triple agonist peptide of the glucagon receptor (GCGR) , glucosedependent insulinotropic polypeptide receptor (GIPR) , and glucagon-like peptide-1 receptor (GLP-1R) . Retatrutide TFA binds human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide TFA can be used for the research of obesity[1].
| Category | Peptide |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Metabolic Disease |
| Format | Solubility: DMSO : ≥ 100 mg/mL;H2O : 20 mg/mL (ultrasonic;adjust pH to 9 with NH3·H2O) |
| Grade | Clinical information: Phase 3 |
| Purity | 99.1% |
| Molecular Formula | C221H342N46O68.xC2HF3O2 |
| Molecular Weight | 4731.33 |
| Storage Conditions | -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Blue Ice |
| Material Safety Data Sheet | Download PDF |
